Mortality in association with antipsychotic medication use and clinical outcomes among geriatric psychiatry outpatients with COVID-19.

ABSTRACT:

Objectives

Older adults are particularly vulnerable to the negative consequences of antipsychotic exposure and are disproportionally affected by higher mortality from coronavirus disease 2019 (COVID-19). Our goal was to determine whether concurrent antipsychotic medication use was associated with increased COVID-19 mortality in older patients with preexisting behavioral health problems. We also report on findings from post-COVID follow-ups.

Design

Retrospective observational study.

Participants

Outpatients at a geriatric psychiatric clinic in New York City.

Measurements

Demographic and clinical data including medication, diagnosis and Clinical Global Impression Severity (CGI-S) scales on outpatients who had COVID-19 between February 28th and October 1st 2020 we

SUBMITTER: Austria B 

PROVIDER: S-EPMC8530340 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature